Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting cushmanwakefield.com to read:%0A%0A {0} %0A%0A {1}
22q1-lifesciencesupdate-mobilehero 22q1-lifesciencesupdate-hero

Insights

Life Sciences Update: October 2022

READ THE FULL REPORT

Following extraordinary investment, expansion, and innovation in 2021, the life sciences industry is poised for further growth and consistent demand in the years ahead.

Going forward, capitalizing on the latest trends in technology will be more critical than ever as these advancements are continuously reshaping the way we research, develop, test, go to market and analyze data in life sciences. Even though its trajectory is intact, the sector is not immune, however, to overarching economic factors like inflation, higher interest rates and tightening capital markets, which are impacting investors and life sciences companies looking to occupy space within a tight budget. 

Life Sciences Market Summaries 

Select each market on the map below to view an in-depth life sciences market summary for that city.

INTERESTED IN MORE?

Read the full report and explore the market-by-market analysis.

Real Estate Fundamentals Remain Strong 

The life sciences sector has experienced outsized growth in the last seven years. U.S. asking rents are 67% higher, on average, than in 2015, and inventory has grown in tandem by 29% across the markets tracked by Cushman & Wakefield Research. UK rents have grown 63% since 2017, on par with U.S. markets. Growth has slowed in some markets but remains above 2019 pre-pandemic levels.

The Impact of the Economic Slowdown

Will the current economic slowdown impact the life sciences sector or is it insulated from recessionary pressures? Life sciences labor has shown resiliency during previous recessionary periods, outperforming major employment sectors. Take a look at sector performance during the last two recessions.

Flow of Funding

The global life sciences venture capital funding market experienced a slowdown in the first half of 2022 relative to the same period in 2021. 

Future Demand

The flow of venture capital into the life sciences sector has accelerated the growth of new companies with seed and early-stage companies still experiencing significant momentum. 

For the markets tracked by Cushman & Wakefield, 50% of the life sciences VC deals through August 2022 involved a seed or early-stage deal, with the average deal size of $38 million.
An indicator of CRE growth and demand among life sciences companies is clinical trials activity. Currently, there are approximately 63,000 active clinical trials among the markets tracked by Cushman & Wakefield.
WEBINAR REPLAY | LIFE SCIENCES UPDATE

This 2022 Life Sciences Update webinar breaks down the current trends in the life sciences industry by exploring:

  • Strength of real estate fundamentals
  • The ongoing labor crunch
  • How the economic slowdown is impacting the industry
  • The continued flow of funding into life sciences
  • REGISTER NOW
    WHAT'S NEXT FOR LIFE SCIENCES?
    Sign up to learn more about what's next for the Life Sciences sector of commercial real estate.
    Subscribe Learn More

     

    Related insights

    Life-Science-Update-Finding-Talent-webcard-v2
    Article • Lab

    Life Science Update: Finding Talent and Fostering New Ideas

    Encouraging collaboration to formulate new ideas and creating access to skilled talent remain priorities for life sciences companies. Among current life science industry trends, there are several hot locations for the life sciences, as well as a focus on amenities that spark ‘spontaneous interactions’.
    Rachel Park • 10/19/2022
    LifeSciences-Checklist_card
    Article • Lab

    Does your building qualify for a life sciences conversion?

    Interest in converting assets for life sciences use is growing amongst building owners. Cushman & Wakefield’s Project & Development Services team developed basic building performance criteria based on the minimum standards that life sciences companies typically require. 
    Daniel Hackett • 7/25/2022
    Life Science
    Article • Lab

    Challenges for Life Sciences Projects Means Early Engagement of Project Managers

    In this current global economy with supply chain hurdles and inflationary pressures, planning a construction project can be challenging.
    Jason D'Orlando • 7/22/2022

    Interested in learning more?

    Get in touch and we can assist with any additional information you need.

    With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

    Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

    You can change your preferences at any time by returning to this site or clicking on  Cookies

    More Options
    Agree and Close
    These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
    These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
    These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
    Agree All
    Reject All
    SAVE SETTINGS